Galectin Therapeutics
GALT
$3.23
Share price
2.87%
Change (1 day)
93.41%
Change (1 year)
Categories
Galectin Therapeutics (GALT) - P/B ratio
P/B ratio as of May 2024 : -3.23
According to Galectin Therapeutics's latest financial reports the company has a price-to-book ratio of -3.23.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Galectin Therapeutics - P/B ratio (from 2002 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -1.70 | -18.29% |
| 2022-12-31 | -2.09 | -104.44% |
| 2021-12-31 | 47.0 | 788.53% |
| 2020-12-31 | 5.28 | 48.08% |
| 2019-12-31 | 3.57 | -82.58% |
| 2018-12-31 | 20.5 | -79.47% |
| 2017-12-31 | 99.8 | 3698.5% |
| 2016-12-31 | 2.63 | 39.18% |
| 2015-12-31 | 1.89 | -31.7% |
| 2014-12-31 | 2.76 | -84.7% |
| 2013-12-31 | 18.1 | 334.23% |
| 2012-12-31 | 4.16 | -75.28% |
| 2011-12-31 | 16.8 | -149.55% |
| 2010-12-31 | -34.0 | 946.9% |
| 2009-12-31 | -3.24 | -64.75% |
| 2008-12-31 | -9.20 | -4.78% |
| 2007-12-31 | -9.66 | -98.55% |
| 2006-12-31 | -665 | -2960.63% |
| 2005-12-31 | 23.3 | 244.07% |
| 2004-12-31 | 6.76 | -45.83% |
| 2003-12-31 | 12.5 | -63.47% |
| 2002-12-31 | 34.2 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Mirati Therapeutics MRTX | 4.35 | -234.83% | 🇺🇸 USA |
 MannKind Corp MNKD | -5.08 | 57.36% | 🇺🇸 USA |